The Albinism Drug market was valued at USD 207.00 Million in 2022 and is expected to reach USD 281.00 Million by 2030, growing at a CAGR of 5.4% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.